207 related articles for article (PubMed ID: 32959474)
1. Myocardial Ischemia Induced by 5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study.
Dyhl-Polk A; Schou M; Vistisen KK; Sillesen AS; Serup-Hansen E; Faber J; Klausen TW; Bojesen SE; Vaage-Nilsen M; Nielsen DL
Oncologist; 2021 Mar; 26(3):e403-e413. PubMed ID: 32959474
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.
Dyhl-Polk A; Vaage-Nilsen M; Schou M; Vistisen KK; Lund CM; Kümler T; Appel JM; Nielsen DL
Acta Oncol; 2020 Apr; 59(4):475-483. PubMed ID: 31931649
[No Abstract] [Full Text] [Related]
3. Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk.
Lestuzzi C; Vaccher E; Talamini R; Lleshi A; Meneguzzo N; Viel E; Scalone S; Tartuferi L; Buonadonna A; Ejiofor L; Schmoll HJ
Ann Oncol; 2014 May; 25(5):1059-64. PubMed ID: 24558023
[TBL] [Abstract][Full Text] [Related]
4. Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study.
Rezkalla S; Kloner RA; Ensley J; al-Sarraf M; Revels S; Olivenstein A; Bhasin S; Kerpel-Fronious S; Turi ZG
J Clin Oncol; 1989 Apr; 7(4):509-14. PubMed ID: 2466960
[TBL] [Abstract][Full Text] [Related]
5. Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study.
Peng J; Dong C; Wang C; Li W; Yu H; Zhang M; Zhao Q; Zhu B; Zhang J; Li W; Wang F; Wu Q; Zhou W; Yuan Y; Qiu M; Chen G
Cancer Commun (Lond); 2018 May; 38(1):22. PubMed ID: 29764506
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
[TBL] [Abstract][Full Text] [Related]
7. Cardiotoxicity of 5-flourouracil: two case reports.
Tutkun A; Inanli S; Caymaz O; Ayanoğlu E; Duman D
Auris Nasus Larynx; 2001 Apr; 28(2):193-6. PubMed ID: 11240331
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of Heart-Type Fatty Acid-Binding Protein and Myocardial Performance Index for Early Detection of 5-Fluorouracil Cardiotoxicity.
Turan T; Agac MT; Aykan AÇ; Kul S; Akyüz AR; Gökdeniz T; Gül İ; Cengiz E; Boyacı F; Erkan H; Akdemir R; Celik S
Angiology; 2017 Jan; 68(1):52-58. PubMed ID: 26980771
[TBL] [Abstract][Full Text] [Related]
9. Bolus 5-Fluorouracil as an alternative modality to infusion 5-Fluorouracil in a patient with rectal cancer and capecitabine-induced cardiotoxicity.
Shaib W; Lee V; Saif MW
In Vivo; 2009; 23(5):821-6. PubMed ID: 19779118
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of silent ischemia in patients with previous myocardial infarct, under 45 years of age].
Agoas R; Gomes V; Leiria G
Rev Port Cardiol; 1990 Jun; 9(6):521-5. PubMed ID: 2248787
[TBL] [Abstract][Full Text] [Related]
11. 5-fluorouracil-based therapy induces endovascular injury having potential significance to development of clinically overt cardiotoxicity.
Jensen SA; Sørensen JB
Cancer Chemother Pharmacol; 2012 Jan; 69(1):57-64. PubMed ID: 21603868
[TBL] [Abstract][Full Text] [Related]
12. EVALUATION OF 5-FLUOROURACIL-INDUCED CARDIOTOXICITY: ROLE OF CARDIAC BIOMARKERS.
Moghaddam Z; Rostami M; Zeraatchi A; Abadi H; Karamitanha F; Amirmoghaddami H
Exp Oncol; 2022 May; 44(1):60-66. PubMed ID: 35548958
[TBL] [Abstract][Full Text] [Related]
13. Failure of oral nitrate and calcium channel blocker therapy to prevent 5-fluorouracil-related myocardial ischemia: a case report.
Akpek G; Hartshorn KL
Cancer Chemother Pharmacol; 1999; 43(2):157-61. PubMed ID: 9923822
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study.
Kosmas C; Kallistratos MS; Kopterides P; Syrios J; Skopelitis H; Mylonakis N; Karabelis A; Tsavaris N
J Cancer Res Clin Oncol; 2008 Jan; 134(1):75-82. PubMed ID: 17636329
[TBL] [Abstract][Full Text] [Related]
15. A case of 5-fluorouracil cardiotoxicity simulating acute myocardial infarction.
Mizuno Y; Hokamura Y; Kimura T; Kimura Y; Kaikita K; Yasue H
Jpn Circ J; 1995 May; 59(5):303-7. PubMed ID: 7596036
[TBL] [Abstract][Full Text] [Related]
16. The additive value of copeptin for early diagnosis and prognosis of acute coronary syndromes.
Ahmed TAN; Johny JS; Abdel-Malek MY; Fouad DA
Am J Emerg Med; 2021 Dec; 50():413-421. PubMed ID: 34481261
[TBL] [Abstract][Full Text] [Related]
17. How silent is perioperative myocardial ischemia? A hemodynamic, electrocardiographic, and biochemical study in patients undergoing coronary artery bypass graft surgery.
Tupper-Carey DA; Newman DJ; Price CP; Walesby RK; Ridout DA; Feneck RO
J Cardiothorac Vasc Anesth; 2000 Apr; 14(2):144-50. PubMed ID: 10794332
[TBL] [Abstract][Full Text] [Related]
18. [Cardiotoxicity of 5-fluorouracil].
Pan L; Yang X; Song H
Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):86-9. PubMed ID: 8758800
[TBL] [Abstract][Full Text] [Related]
19. Fluoropyrimidine-associated cardiotoxicity: revisited.
Saif MW; Shah MM; Shah AR
Expert Opin Drug Saf; 2009 Mar; 8(2):191-202. PubMed ID: 19309247
[TBL] [Abstract][Full Text] [Related]
20. 5-FU-induced cardiac toxicity--an underestimated problem in radiooncology?
Steger F; Hautmann MG; Kölbl O
Radiat Oncol; 2012 Dec; 7():212. PubMed ID: 23241239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
